ClinicalTrials.gov: nanoparticle AND radiotherapy | Last update posted in the last 14 days
Radiotherapy of Multiple Brain Metastases Using AGuIX®
Mon, 28 Jan 2019 12:00:00 EST
Conditions:   Brain Metastases, Adult;   Radiotherapy
Interventions:   Drug: AGuIX®;   Radiation: Whole Brain Radiation Therapy
Sponsors:   University Hospital, Grenoble;   NH TherAguix SAS
Recruiting
Reirradiation by Nanoparticles and Hypofractionated Protontherapy of Relapses Tumors: Non-randomized Phase II Study.
Fri, 05 Mar 2021 12:00:00 EST
Conditions:   Recurrent Cancer;   Previous Radiation
Intervention:   Radiation: Radiation by protontherapy associated to nanoparticles injection
Sponsor:   Centre Francois Baclesse
Not yet recruiting
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Mon, 27 Jan 2020 12:00:00 EST
Condition:   Neoplasms of the Prostate
Intervention:   Device: AuroShell particle infusion
Sponsor:   Nanospectra Biosciences, Inc.
Recruiting
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Thu, 11 Feb 2016 12:00:00 EST
Condition:   Neoplasms of the Prostate
Intervention:   Device: AuroShell particle infusion
Sponsor:   Nanospectra Biosciences, Inc.
Completed
A Study of Efficacy of Zinc Oxide Nanoparticles Coated Socks in Prevention of Unpleasant Foot Odor
Thu, 27 Jun 2019 12:00:00 EDT
Conditions:   Zinc Oxide;   Foot Dermatoses
Interventions:   Other: zinc oxide nanoparticles coated socks;   Other: placebo socks
Sponsor:   Mahidol University
Completed
Trial of NanoPac Intratumoral Injection in Lung Cancer
Thu, 19 Mar 2020 12:00:00 EDT
Conditions:   Lung Cancer, Nonsmall Cell;   Lung Cancer;   Lung Cancer, Small Cell;   Neoplasm of Lung
Intervention:   Drug: NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
Sponsors:   NanOlogy, LLC;   US Biotest, Inc.
Recruiting
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Wed, 12 Feb 2020 12:00:00 EST
Conditions:   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Invasive Breast Carcinoma;   Prognostic Stage II Breast Cancer AJCC v8;   Prognostic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8
Interventions:   Drug: Docetaxel;   Procedure: Lumpectomy;   Procedure: Mastectomy;   Drug: Nab-paclitaxel;   Drug: Paclitaxel;   Biological: Pertuzumab;   Radiation: Radiation Therapy;   Biological: Trastuzumab;   Biological: Trastuzumab Emtansine
Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI)
Recruiting
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
Tue, 17 Mar 2020 12:00:00 EDT
Conditions:   Metastatic Lung Non-Squamous Non-Small Cell Carcinoma;   Recurrent Lung Non-Squamous Non-Small Cell Carcinoma;   Stage III Lung Cancer AJCC v8;   Stage IIIA Lung Cancer AJCC v8;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIC Lung Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Unresectable Lung Non-Squamous Non-Small Cell Carcinoma
Interventions:   Drug: Cabozantinib S-malate;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride;   Drug: Nab-paclitaxel;   Biological: Nivolumab;   Drug: Paclitaxel;   Biological: Ramucirumab
Sponsor:   National Cancer Institute (NCI)
Recruiting
Feed Fetched by RSS Dog.